Ribavirin

Product introduction:

Ribavirin, a nucleoside analogue of guanosine and hypoxanthine, is a broad-spectrum antiviral drug, which has a good inhibitory effect on a variety of DNA and RNA viruses. It has the characteristics of many action sites, not easy to produce drug resistance, high curative effect, low toxicity and small side effects. It has been used in the treatment of a variety of viruses. It is clinically used to treat hepatitis C virus, respiratory syncytial virus and Lassa fever virus infection.

CAS：36791-04-5

Structural type:

Molecular formula: C₈H₁₂N₄O₅

Molecular weight: 244.21

Purpose:

Ribavirin is widely used in medicine. It has high curative effects on hepatitis A, influenza, all kinds of herpes, respiratory syncytial virus, human immunodeficiency virus, epidemic hemorrhagic fever virus infection and skin diseases. Ribavirin is the only effective drug for the treatment of respiratory syncytial virus and the first choice for the treatment of epidemic hemorrhagic fever. In recent years, its application in hepatitis B and hepatitis C also showed better results. In India, the drug was approved for the treatment of acute hepatitis, respiratory tract infection and herpes simplex infection. In Britain, Switzerland, Italy, the United States and other countries, it was approved as a preventive drug for AIDS. In 2003, Canada and Hongkong were used as the early treatment of SARS virus.